Intrinsiqs

Is Boundless Bio, Inc. overvalued?

Boundless Bio, Inc. (BOLD) — key valuation metrics and fundamentals.

No verdict
Price
$2.50
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$56.9M
Dividend yield
0.0%
Return on equity
-71.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BOLD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.